Award-Winning Cancer Care

The Mount Sinai Comprehensive Cancer Center is a nationally recognized, award-winning facility that utilizes a collaborative, multidisciplinary approach to diagnosing and treating cancer. We provide quality care, leading innovation and personalized treatment plans for each patient to treat a broad range of cancers. Our patient-centered focus ensures access to convenient, timely appointments, clinical trials and a host of support services all aimed at helping patients heal.

Mount Sinai is the first hospital in Florida, and one of only 36 in the U.S., to receive its third consecutive Outstanding Achievement Award from the American College of Surgeons Commission on Cancer (CoC). The CoC created this award to recognize programs that strive for excellence in providing quality cancer care.

In addition, our radiation oncology program was the first in South Florida to earn accreditation from the American College of Radiology. This accreditation represents the highest level of quality and patient safety, and is awarded to facilities meeting specific practice guidelines and technical standards. As a recognized radiation safety provider, Mount Sinai has strict safety measures in place to ensure that patients receive radiation only when it is necessary and in the smallest possible dosage.


Cancer Research

The Mount Sinai Comprehensive Cancer Center offers one of the most integrated cancer research programs in the state. The Mount Sinai Cancer Research Program gives patients the opportunity to participate in innovative clinical trials that offer new cancer treatment options before they become available to the general public. Our program is currently engaged in more than 65 active clinical trials, placing Mount Sinai at the forefront among the nation’s cancer research institutions. Many of our protocols have resulted in cutting-edge cancer treatments.

Advanced Technology

Mount Sinai is committed to applying major technological advances in the diagnosis and treatment of cancer. We are among a select few hospitals in the nation to acquire the SPECT-CT, a state-of-the-art imaging system for the diagnosis and treatment of cancer, cardiac and orthopaedic conditions. SPECT-CT uses advanced molecular technology to produce highly detailed 3-D anatomic images. This system gives physicians the best available visual information to precisely plan therapy, radiation or surgical procedures. SPECT-CT also aids in tumor staging and in determining efficacy of treatment.

Mount Sinai was the first Florida hospital with the Evident™ ablation system, which destroys tumors in the kidneys, liver, lungs and other soft tissues using microwave energy.

The Lila and Harold Menowitz Comprehensive Breast Center

Breast cancer is the leading cause of cancer death among women of all races in the United States, with one of every eight women susceptible to the disease. Mount Sinai’s Lila and Harold Menowitz Comprehensive Breast Center gives patients access to a full range of screening, diagnostic, counseling and support services. Mount Sinai offers comprehensive breast cancer services at two convenient locations, Miami Beach and Aventura.

The Menowitz Breast Center is the first facility in Florida to receive accreditation from the National Accreditation Program for Breast Centers and has been recognized as a Breast Imaging Center of Excellence by the American College of Radiology.

New Treatments for Prostate Cancer

Our oncologists offer a wide array of technologically advanced treatment options for prostate cancer patients with the objective of providing the most effective responses, the greatest amount of patient comfort and the swiftest recovery times. This includes RapidARC™  radiation therapy, radiation seed implants, brachytherapy and PROVENGE®, a new therapeutic drug for patients with advanced prostate cancer.

Oncology Conferences

The doctors at Mount Sinai participate in ongoing conferences that bring together a diverse group of specialists to analyze and review individual patient cases, all in an effort to enhance the safety and effectiveness of each patient’s treatment. Participants include oncologists, surgical oncologists, radiation oncologists, pathologists and other specialists.